MLICM
OPTN

Metropolitan Life Insurance Company (MetLife)’s OptiNose OPTN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-269
Closed -$5.88K – 1477
2024
Q1 		$5.88K Buy
+269
New +$5.97K ﹤0.01% 2237
2020
Q3 		– Sell
-739
Closed -$82.4K – 2584
2020
Q2 		$82.4K Buy
+739
New +$52.6K ﹤0.01% 2364
2018
Q4 		– Sell
-383
Closed -$71.4K – 2564
2018
Q3 		$71.4K Buy
+383
New +$109K ﹤0.01% 2536

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s OPTN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of OptiNose (OPTN) in Q2 2024, closing a stake of 269 shares — an estimated $5.88K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OPTN in Q3 2018 and held it in 3 quarters. The position peaked at $82.4K in Q2 2020. 84 funds tracked by Wall St. Rank hold OPTN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining OptiNose position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 269 OptiNose shares in Q2 2024, an estimated $5.88K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in OptiNose in Q3 2018 and held it in 3 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s OptiNose position peaked at $82.4K in Q2 2020.
  • 84 funds tracked by Wall St. Rank held OptiNose as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.